Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Actinic Keratosis (AK) Treatment in 2020

By: Theodore Rosen, MD, FAAD

Webinar Credits: .5

Expiration Date: Friday, October 01, 2021
Release Date: Sept 7, 2020

Learning Objectives

After this activity, the learner should be able to:

  • Understand better the patients’ perceptions about AK
  • Adopt innovative use of traditional agents
  • Become aware of new, high tech approaches to AK therapy

Accreditation and Designation Statement

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, the Dermatology Education Foundation, and Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
Evolve Medical Education, LLC designates this enduring material for a maximum of .5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA CONTINUING EDUCATION
PAs may claim a maximum of .5 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

NURSE PRACTITIONER CONTINUING EDUCATION
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Faculty and Disclosures

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Theodore Rosen, MD, FAAD and/or spouse has no financial agreement or affiliations with the commercial interests.

The staff and planners from Evolve Medical Education and Physician Resources have no financial agreement or affiliations with commercial interests.

Test

Instructions

Step 1 of 2

  • AgreeNeutralDisagree
    Understand better the patients’ perceptions about AK
    Adopt innovative use of traditional agents
    Become aware of new, high tech approaches to AK therapy
Back